Cargando…
A protein kinase Cβ inhibitor attenuates multidrug resistance of neuroblastoma cells
BACKGROUND: The acquisition of drug resistance is a major reason for poor outcome of neuroblastoma. Protein kinase C (PKC) has been suggested to influence drug resistance in cancer cells. The aim of this study was to elucidate whether inhibition of PKCβ isoforms influences drug-resistance of neurobl...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2003
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC153510/ https://www.ncbi.nlm.nih.gov/pubmed/12697075 http://dx.doi.org/10.1186/1471-2407-3-10 |